Millicom International Cellular S.A. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Millicom International Cellular S.A. Common Stock trades at $80.5 (market cap $13.34B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Millicom International Cellular S.A. Common Stock is far larger — about 7.4× Vir Biotechnology Inc. Common Stock's market cap, and Millicom International Cellular S.A. Common Stock pays a 3.77% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Millicom International Cellular S.A. Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| TIGO | VIR | |
|---|---|---|
Market Cap | $13.34B | $1.80B |
Volume | 1,586,684 | 1,782,836 |
Sector | Media | Health |
52-Week High | $104.31 | $11.78 |
52-Week Low | $45.81 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $24.38B | $1.36B |
Dividend Yield | 3.77% | — |
Signals from Pluang's Aura AI — not financial advice
TIGO trades at $79.54, down 0.92% on the day, with a neutral technical signal and key support at $79. The company reported strong 2025 results with $5.82B revenue and $1.32B net income, but 2026 earnings have missed expectations in two of the last three quarters. Recent news highlights its addition to Zacks' Strong Buy list and a consistent $0.75 quarterly dividend.
The stock offers a 12.9% upside to the consensus price target of $89.78, supported by solid profitability and cash flow, but faces risks from earnings volatility and high debt. Analyst sentiment is mixed with a Hold consensus, suggesting cautious optimism amid integration challenges from recent acquisitions.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Millicom International Cellular S.A. operates telecommunications and digital services under the Tigo brand across Latin America, providing mobile, fiber broadband, and pay-TV services. The company also offers mobile financial services through its Tigo Money business.
Read more on TIGO →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →